Chronic diseases are closely linked to alterations in body composition, yet there is a need for reliable biomarkers to assess disease risk and progression. This study aimed to develop and validate a biological age indicator based on body composition derived from dual-energy X-ray absorptiometry (DXA) scans, offering a novel approach to evaluating health status and predicting disease outcomes. A deep learning model was trained on a reference population from the UK Biobank to estimate body composition biological age (BCBA). The model's performance was assessed across various groups, including individuals with typical and atypical body composition, those with pre-existing diseases, and those who developed diseases after DXA imaging. Key metrics such as c-index were employed to examine BCBA's diagnostic and prognostic potential for type 2 diabetes, major adverse cardiovascular events (MACE), atherosclerotic cardiovascular disease (ASCVD), and hypertension. Here we show that BCBA strongly correlates with chronic disease diagnoses and risk prediction. BCBA demonstrated significant associations with type 2 diabetes (odds ratio 1.08 for females and 1.04 for males, p < 0.0005), MACE (odds ratio 1.10 for females and 1.11 for males, p < 0.0005), ASCVD (odds ratio 1.07 for females and 1.10 for males, p < 0.0005), and hypertension (odds ratio 1.06 for females and 1.04 for males, p < 0.0005). It outperformed standard cardiovascular risk profiles in predicting MACE and ASCVD. BCBA is a promising biomarker for assessing chronic disease risk and progression, with potential to improve clinical decision-making. Its integration into routine health assessments could aid early disease detection and personalised interventions.

Congenital Heart Disease (CHD) remains a leading cause of infant morbidity and mortality, yet non-invasive screening methods often yield false negatives. Deep learning models, with their ability to automatically extract features, can assist doctors in detecting CHD more effectively. In this work, we investigate the use of dual-modality (sound and image) deep learning methods for CHD diagnosis. We achieve 73.9% accuracy on the ZCHSound dataset and 80.72% accuracy on the DICOM Chest X-ray dataset.

Inhalation injuries face a challenge in clinical diagnosis and grading due to the limitations of traditional methods, such as Abbreviated Injury Score (AIS), which rely on subjective assessments and show weak correlations with clinical outcomes. This study introduces a novel deep learning-based framework for grading inhalation injuries using bronchoscopy images with the duration of mechanical ventilation as an objective metric. To address the scarcity of medical imaging data, we propose enhanced StarGAN, a generative model that integrates Patch Loss and SSIM Loss to improve synthetic images' quality and clinical relevance. The augmented dataset generated by enhanced StarGAN significantly improved classification performance when evaluated using the Swin Transformer, achieving an accuracy of 77.78%, an 11.11% improvement over the original dataset. Image quality was assessed using the Fr\'echet Inception Distance (FID), where Enhanced StarGAN achieved the lowest FID of 30.06, outperforming baseline models. Burn surgeons confirmed the realism and clinical relevance of the generated images, particularly the preservation of bronchial structures and color distribution. These results highlight the potential of enhanced StarGAN in addressing data limitations and improving classification accuracy for inhalation injury grading.

Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the leading cause of dementia worldwide and remains incurable once it begins. Therefore, early and accurate diagnosis is essential for effective intervention. Leveraging recent advances in deep learning, this study proposes a novel diagnostic model based on the 3D-ResNet architecture to classify three cognitive states: AD, mild cognitive impairment (MCI), and cognitively normal (CN) individuals, using MRI data. The model integrates the strengths of ResNet and 3D convolutional neural networks (3D-CNN), and incorporates a special attention mechanism(SAM) within the residual structure to enhance feature representation. The study utilized the ADNI dataset, comprising 800 brain MRI scans. The dataset was split in a 7:3 ratio for training and testing, and the network was trained using data augmentation and cross-validation strategies. The proposed model achieved 92.33% accuracy in the three-class classification task, and 97.61%, 95.83%, and 93.42% accuracy in binary classifications of AD vs. CN, AD vs. MCI, and CN vs. MCI, respectively, outperforming existing state-of-the-art methods. Furthermore, Grad-CAM heatmaps and 3D MRI reconstructions revealed that the cerebral cortex and hippocampus are critical regions for AD classification. These findings demonstrate a robust and interpretable AI-based diagnostic framework for AD, providing valuable technical support for its timely detection and clinical intervention.

The risk of postoperative pancreatic fistula (POPF), one of the most dreaded complications after pancreatic surgery, can be predicted from preoperative imaging and tabular clinical routine data. However, existing studies suffer from limited clinical applicability due to a need for manual data annotation and a lack of external validation. We propose AutoFRS (automated fistula risk score software), an externally validated end-to-end prediction tool for POPF risk stratification based on multimodal preoperative data. We trained AutoFRS on preoperative contrast-enhanced computed tomography imaging and clinical data from 108 patients undergoing pancreatic head resection and validated it on an external cohort of 61 patients. Prediction performance was assessed using the area under the receiver operating characteristic curve (AUC) and balanced accuracy. In addition, model performance was compared to the updated alternative fistula risk score (ua-FRS), the current clinical gold standard method for intraoperative POPF risk stratification. AutoFRS achieved an AUC of 0.81 and a balanced accuracy of 0.72 in internal validation and an AUC of 0.79 and a balanced accuracy of 0.70 in external validation. In a patient subset with documented intraoperative POPF risk factors, AutoFRS (AUC: 0.84 ± 0.05) performed on par with the uaFRS (AUC: 0.85 ± 0.06). The AutoFRS web application facilitates annotation-free prediction of POPF from preoperative imaging and clinical data based on the AutoFRS prediction model. POPF can be predicted from multimodal clinical routine data without human data annotation, automating the risk prediction process. We provide additional evidence of the clinical feasibility of preoperative POPF risk stratification and introduce a software pipeline for future prospective evaluation.

Identifying brain hemorrhages from magnetic resonance imaging (MRI) is a critical task for healthcare professionals. The diverse nature of MRI acquisitions with varying contrasts and orientation introduce complexity in identifying hemorrhage using neural networks. For acquisitions with varying orientations, traditional methods often involve resampling images to a fixed plane, which can lead to information loss. To address this, we propose a 3D multi-plane vision transformer (MP-ViT) for hemorrhage classification with varying orientation data. It employs two separate transformer encoders for axial and sagittal contrasts, using cross-attention to integrate information across orientations. MP-ViT also includes a modality indication vector to provide missing contrast information to the model. The effectiveness of the proposed model is demonstrated with extensive experiments on real world clinical dataset consists of 10,084 training, 1,289 validation and 1,496 test subjects. MP-ViT achieved substantial improvement in area under the curve (AUC), outperforming the vision transformer (ViT) by 5.5% and CNN-based architectures by 1.8%. These results highlight the potential of MP-ViT in improving performance for hemorrhage detection when different orientation contrasts are needed.

According to the updated classification system, human epidermal growth factor receptor 2 (HER2) expression statuses are divided into the following three groups: HER2-over-expression, HER2-low-expression, and HER2-zero-expression. HER2-negative expression was reclassified into HER2-low-expression and HER2-zero-expression. This study aimed to identify three different HER2 expression statuses for breast cancer (BC) patients using PET/CT radiomics and clinicopathological characteristics. A total of 315 BC patients who met the inclusion and exclusion criteria from two institutions were retrospectively included. The patients in institution 1 were divided into the training set and the independent validation set according to the ratio of 7:3, and institution 2 was used as the external validation set. According to the results of pathological examination, all BC patients were divided into HER2-over-expression, HER2-low-expression, and HER2-zero-expression. First, PET/CT radiomic features and clinicopathological features based on each patient were extracted and collected. Second, multiple methods were used to perform feature screening and feature selection. Then, four machine learning classifiers, including logistic regression (LR), k-nearest neighbor (KNN), support vector machine (SVM), and random forest (RF), were constructed to identify HER2-over-expression vs. others, HER2-low-expression vs. others, and HER2-zero-expression vs. others. The receiver operator characteristic (ROC) curve was plotted to measure the model's predictive power. According to the feature screening process, 8, 10, and 2 radiomics features and 2 clinicopathological features were finally selected to construct three prediction models (HER2-over-expression vs. others, HER2-low-expression vs. others, and HER2-zero-expression vs. others). For HER2-over-expression vs. others, the RF model outperformed other models with an AUC value of 0.843 (95%CI: 0.774-0.897), 0.785 (95%CI: 0.665-0.877), and 0.788 (95%CI: 0.708-0.868) in the training set, independent validation set, and external validation set. Concerning HER2-low-expression vs. others, the outperformance of the LR model over other models was identified with an AUC value of 0.783 (95%CI: 0.708-0.846), 0.756 (95%CI: 0.634-0.854), and 0.779 (95%CI: 0.698-0.860) in the training set, independent validation set, and external validation set. Whereas, the KNN model was confirmed as the optimal model to distinguish HER2-zero-expression from others, with an AUC value of 0.929 (95%CI: 0.890-0.958), 0.847 (95%CI: 0.764-0.910), and 0.835 (95%CI: 0.762-0.908) in the training set, independent validation set, and external validation set. Combined PET/CT radiomic models integrating with clinicopathological characteristics are non-invasively predictive of different HER2 statuses of BC patients.

Alveolar echinococcosis (AE) is a parasitic disease caused by Echinococcus multilocularis, where early detection is crucial for effective treatment. This study introduces a novel method for the early diagnosis of liver diseases by differentiating between tumor, AE, and healthy cases using non-contrast CT images, which are widely accessible and eliminate the risks associated with contrast agents. The proposed approach integrates an automatic liver region detection method based on RCNN followed by a CNN-based classification framework. A dataset comprising over 27,000 thorax-abdominal images from 233 patients, including 8206 images with liver tissue, was constructed and used to evaluate the proposed method. The experimental results demonstrate the importance of the two-stage classification approach. In a 2-class classification problem for healthy and non-healthy classes, an accuracy rate of 0.936 (95% CI: 0.925 <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>-</mo></math> 0.947) was obtained, and that for 3-class classification problem with AE, tumor, and healthy classes was obtained as 0.863 (95% CI: 0.847 <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>-</mo></math> 0.879). These results highlight the potential use of the proposed framework as a fully automatic approach for liver classification without the use of contrast agents. Furthermore, the proposed framework demonstrates competitive performance compared to other state-of-the-art techniques, suggesting its applicability in clinical practice.

Given the current limited accuracy of imaging screening for Hepatic Echinococcosis (HCE) in under-resourced areas, the authors developed and validated a Multimodal Imaging system (HEAC) based on plain Computed Tomography (CT) combined with ultrasound for HCE screening in those areas. In this study, we developed a multimodal deep learning diagnostic system by integrating ultrasound and plain CT imaging data to differentiate hepatic echinococcosis, liver cysts, liver abscesses, and healthy liver conditions. We collected a dataset of 8979 cases spanning 18 years from eight hospitals in Xinjiang China, including both retrospective and prospective data. To enhance the robustness and generalization of the diagnostic model, after modeling CT and ultrasound images using EfficientNet3D and EfficientNet-B0, external and prospective tests were conducted, and the model's performance was compared with diagnoses made by experienced physicians. Across internal and external test sets, the fused model of CT and ultrasound consistently outperformed the individual modality models and physician diagnoses. In the prospective test set from the same center, the fusion model achieved an accuracy of 0.816, sensitivity of 0.849, specificity of 0.942, and an AUC of 0.963, significantly exceeding physician performance (accuracy 0.900, sensitivity 0.800, specificity 0.933). The external test sets across seven other centers demonstrated similar results, with the fusion model achieving an overall accuracy of 0.849, sensitivity of 0.859, specificity of 0.942, and AUC of 0.961. The multimodal deep learning diagnostic system that integrates CT and ultrasound significantly increases the diagnosis accuracy of HCE, liver cysts, and liver abscesses. It beats standard single-modal approaches and physician diagnoses by lowering misdiagnosis rates and increasing diagnostic reliability. It emphasizes the promise of multimodal imaging systems in tackling diagnostic issues in low-resource areas, opening the path for improved medical care accessibility and outcomes.

Chronic pain is a multifactorial condition presenting significant diagnostic and prognostic challenges. Biomarkers for the classification and the prediction of chronic pain are therefore critically needed. Here, in this multidataset study of over 523,000 participants, we applied machine learning to multidimensional biological data from the UK Biobank to identify biomarkers for 35 medical conditions associated with pain (for example, rheumatoid arthritis and gout) or self-reported chronic pain (for example, back pain and knee pain). Biomarkers derived from blood immunoassays, brain and bone imaging, and genetics were effective in predicting medical conditions associated with chronic pain (area under the curve (AUC) 0.62-0.87) but not self-reported pain (AUC 0.50-0.62). Notably, all biomarkers worked in synergy with psychosocial factors, accurately predicting both medical conditions (AUC 0.69-0.91) and self-reported pain (AUC 0.71-0.92). These findings underscore the necessity of adopting a holistic approach in the development of biomarkers to enhance their clinical utility.